Fossilized teeth in Ethiopia reveal two human ancestors coexisted 2.6 million years ago, including a potentially unknown species
Fossilized teeth unearthed in Ethiopia's Afar Region show early Homo and Australopithecus lived side by side 2.6 million years ago, hinting at a previously unknown species
A groundbreaking discovery in Ethiopia's Afar Region has unveiled evidence that multiple human ancestor species coexisted approximately 2.6 to 2.8 million years ago, challenging traditional views of human evolution. The findings, published in the journal Nature, suggest a more complex and branching evolutionary history than previously understood.
The excavation, part of the Ledi-Geraru Research Project, unearthed 13 fossilized teeth, 10 attributed to a previously unidentified species of Australopithecus and 3 to early members of the Homo genus.
These discoveries indicate that at least five hominin species may have coexisted in eastern Africa during this period, including Homo, Australopithecus, and Paranthropus.
The Australopithecus teeth found at the LD 750 and LD 760 sites exhibit distinct morphological features not seen in known species such as A. afarensis or A. garhi, suggesting the presence of a previously unknown lineage. This challenges the long-held belief that Australopithecus species had disappeared before the emergence of Homo.
The three Homo teeth, dated between 2.78 and 2.59 million years ago, are consistent with early members of the Homo genus, such as Homo habilis. This supports the notion that Homo species were present in the region during the same timeframe as Australopithecus.
The Afar Region's geological activity, including tectonic rifting and volcanic ash deposits, has preserved these fossils exceptionally well, allowing for precise dating and detailed morphological analysis.This discovery underscores the complexity of human evolution, highlighting that multiple hominin species may have coexisted and interacted in overlapping environments. The findings contribute to a more nuanced understanding of our evolutionary history, moving beyond the simplistic linear models previously proposed.Further research and additional fossil discoveries are needed to fully comprehend the relationships and interactions among these ancient human ancestors.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
Dormant Cancer: COVID, flu viruses can awaken dormant cancer cells, finds US study: Know what it means and how serious it is
Scientists at the University of Colorado set out to crack the mystery of why some cancer survivors suddenly face their cancer coming back (metastasis), sometimes years after treatment. Tired of too many ads? go ad free now The culprit, it turns out, might be infections from respiratory viruses like influenza and SARS-CoV-2 (the virus that causes COVID-19). These common bugs, which most of us get at least occasionally, can spark inflammation throughout the body. And for dormant cancer cells—called disseminated cancer cells or DCCs—this inflammation is a loud wake-up call. Here's what they did: Researchers used mouse models of breast cancer to see how infections affected these sleeping cancer cells. They infected the mice with either influenza or SARS-CoV-2. What happened next was jaw-dropping: Within just three days, the number of DCCs in the lungs shot up. Not only that, these cells were way more likely to 'wake up' and grow. In fact, the number remained high for months after infection. So, those cancer cells that had almost disappeared quietly multiplied again, due to the infection. The findings of the study have been published in Nature journal. Digging deeper, the team found a key player: an inflammatory molecule called IL-6. Mice that couldn't make IL-6 didn't see the same explosion of DCCs after infection. This means IL-6 acts like a middleman, triggering dormant cancer cells to get back into action. Even the immune system wasn't off the hook. They spotted that CD4+ T cells—a type of immune cell—were actually helping these newly active cancer cells by holding back another part of the immune system, the CD8+ T cells, which would normally hunt and destroy cancer cells. Tired of too many ads? go ad free now When researchers zapped the CD4+ T cells, more CD8+ T cells got to work and wiped out more cancer. But that's mice. What about people? The researchers checked large health record databases in the UK, looking at people who had been in cancer remission. Those who got COVID-19 had nearly double the risk of dying from cancer than those who didn't get the virus. In another large group of women with breast cancer, getting COVID increased the risk of the cancer spreading to the lungs by about 40%. That's a serious bump. So, what does it mean for cancer survivors? This study suggests that respiratory viruses—including those we might take for granted—could play a hidden role in cancer coming back, especially in the lungs. It doesn't mean every cold or bout of flu will trigger a problem, but for people who've beaten cancer once, it's one more reason to take infections seriously and consider preventive steps when possible. Doctors and scientists are now on the lookout for ways to block this process—perhaps by targeting that IL-6 molecule or tweaking the immune response—to help keep those cancer 'embers' from getting fanned into flames again. If you're a cancer survivor, staying up to date with vaccinations, practicing good hygiene, and talking to your doctor about risk during cold, flu, and COVID seasons could be even more important than you realized. It's not just about dodging a tough week in bed—it's about keeping those lurking cancer cells asleep, for good.
Hindustan Times
a day ago
- Hindustan Times
Seeing Silicon: A bot to tackle blood clots
When I first saw a demo of the milli-spinner in Stanford Robotics Center, it reminded me of a 1966 film Fantastic Voyage in which a submarine crew is shrunk to microscopic size and ventures into the body of an injured scientist to repair the damage to his brain. Except scientists at the Stanford University imagined a more efficient way of dispensing targeted drug inside a human body – a worm-sized robot that can travel through veins and compress a blood clot, treating strokes and heart attacks. The milli-spinner prototype takes up a small display in the medical robotics room. What looms in the room when I enter are larger robots used for imaging and surgery. The millirobot in comparison is less than one centimeter in size. It moves like a tiny worm inside a web of transparent tubes, controlled by a magnetic field. The hollow tube, barely visible unless you bend closer and have a look, rotates rapidly using a series of slits. It was this movement that took mechanical engineer Dr Renee Zhao, the head of the lab and the creator of the robot, years to master. The movement made all the difference. 'With existing technology, there was no way to reduce the size of a blood clot. They relied on deforming and rupturing the clot to remove it,' explains Dr Zhao, assistant professor of mechanical engineering. Once they got the spinning right, the milli-spinner could enter the body through a catheter, draw the clot and compress it before suctioning it out. In a recent scientific paper published in Nature in June 2025, Dr Zhao and her team showed that this new approach to technology – compression before suction - outperformed available treatments in removal of clots from human bloodstream. 'At first, we simply wondered whether this suction could help remove a blood clot,' Zhao said. 'But when we tested the spinner on a clot, we observed a dramatic reduction in volume. Honestly, it felt like magic.' Also Read: Seeing Silicon | Is this year the beginning of the end of smartphones? The more I see and read about the upcoming technologies in medical devices, the more magical it does feel. Stanford's not the first one to develop millirobots, though Zhao has a lot of experience working on millirobots. After the microelectronic advances in the early 2000s, microfabrication allowed engineers to create intricate mechanical and electronic components on a microscopic scale. Due to their small size, microrobots (about one centimetre) and millirobots (less than one centimetre) could be made cheap and could be used in large numbers – like in swarm robotics. However, there was one challenge, and it took technologists another decade to solve it. How do you make these millirobots move through the body without them being tethered to a power source? The microrobots came with small lightweight battery sources but it wasn't enough for them to navigate inside blood vessels or reach hard to reach places. (Just like Fantastic Voyage shows, our blood vessels are complicated rivers to navigate). It was with Wi-Fi, another technology that has dramatically changed our lives, that scientists finally figured out how to control the device inside the body. This level of control meant that these millirobots could become quite useful to deliver precision medicine inside the human body. They could also be used to minimally invasive surgery, diagnostics or navigating blood vessels for treatment. The last decade has seen a flurry of experiments in medical millirobots, the Stanford experiment being one of the latest successful examples of the technology. Some of them have already made it to our hospitals and treatment. For example, biohybrid microswimmers which are created using bacteria, microalgae have been used for advanced medical functions – like targeted therapy of tumours. But most innovations are still in laboratories of research institutions. The next level to these kinds of robots is xenobots, the world's first living robots – built from the heart muscle and stem cells harvested from an early African frog embryo. These AI-designed robots are less than 1 millimetre wide, can simulate a specific task and can work in swarms. They use energy from fat and protein naturally stored in their tissue, which lasts about a week at which point they simply turn into dead skin cells. Future possible uses are treating individuals by creating xenobots using their own cells (reducing the immune response challenge with bots inside your body) and even to aggregate tiny bits of ocean-polluting microplastics into a large ball of plastic to recycle. The latest biorobotics does feel like magic rather than technology, just as Dr Zhao felt when she saw the milli-spinner compress the blood clot. More and more, the technological advances in biomedicine do sound like alchemy to me. Shweta Taneja is an author and journalist based in the Bay Area. Her fortnightly column will reflect on how emerging tech and science are reshaping society in Silicon Valley and beyond. Find her online with @shwetawrites. The views expressed are personal.
Hindustan Times
a day ago
- Hindustan Times
Ancient proteins could transform palaeontology
ANCIENT PROTEINS nestled in fossils contain troves of information about long-dead creatures. However, like all ancient molecules, proteins degrade. Until recently the oldest proteins recovered for reliable, in-depth analysis were around 4m years old. But two separate studies published in Nature on July 9th, one by researchers at Harvard University and the Smithsonian Institution and another led by researchers at the University of Copenhagen, have recovered ancient proteins, some of which could be up to 29m years old. The discoveries should help palaeontologists investigate the behaviour, diet and evolution of animals long thought too old to be studied with molecular tools. Both research teams recovered the ancient proteins from tooth enamel, the hardest substance in vertebrates' bodies, in fossils they assessed to be many millions of years old. They first ground the enamel to a powder and then applied a chemical solution to draw out the proteins. To confirm that the proteins were not the result of modern contamination, they identified chemical damage to the proteins accrued over time, a process called diagenesis. The amount of damage lined up with what they would expect for fossils of that age. The team from Harvard and the Smithsonian Institution focused on the enamel of big African animals, such as elephants, in Kenya's Turkana Basin, which were between 1.5m and 29m years old (although they have high confidence only in fossils up to the age of 18m). Finding old proteins in one of the warmest places on Earth, where biological molecules easily break down, suggested that even older proteins could be recovered in better conditions. The researchers from Copenhagen confirmed this suspicion. In the Haughton Crater in the much colder climes of the Canadian Arctic, they managed to extract protein sequences from the tooth of a 24m-year-old rhinocerotid, a squat, single-horned mammal in the rhinoceros family. Having recovered the proteins, the two teams were able to compare their sequen-ces against databases of known protein sequences from other species. This allowed them to place the extinct species on the tree of life. For example, the Harvard study suggests that an 18m-year-old creature in the Anthracotheriidae family is probably the ancestor of modern hippos, whereas the close relatives of a rhino-like animal called Arsinoitherium, thought to be 29m years old, are all extinct. Enrico Cappellini, who was part of the Copenhagen study, says that the new discoveries expand the timeline of proteins available for analysis ten-fold compared with ancient DNA (aDNA), which lasts about 1m years. That means palaeontologists can now understand the evolution of organisms that are too old for other ancient molecular analysis. Future analyses of carbon and nitrogen isotopes within the preserved proteins could also offer insights into the diet, environment and migratory behaviour of extinct species. There are tantalising hints that scientists may have even older proteins to discover. Back in 2009, researchers from North Carolina State University retrieved fragments of collagen protein from the fossil of an 80m-year-old duck-billed dinosaur called Brachylophosaurus canadensis. Although the collagen had degraded into small bits, they were able to confirm that it was of a specific kind now only found in birds. Better preserved proteins yet to be found might be able to reveal even more. Commenting on the Copenhagen findings, Matthew Collins, a palaeoproteomics expert at the University of Cambridge who was not part of either study, says the results are 'spectacular if true' and that they could transform interpretation of fossil records. Because some proteins in tooth enamel vary between the sexes, they could help determine the sex of some fossils, which can otherwise be tricky. Placing species on the tree of life could also clear up long-running evolutionary disputes, such as the debate over the true ancestry of horses. Whereas aDNA took palaeontologists into the distant past, it seems ancient proteins could take them further still. Curious about the world? To enjoy our mind-expanding science coverage, sign up to Simply Science, our weekly subscriber-only newsletter.
